2026 Optometrist Report

2026 Optometrist Report

Download the free report to understand how optometrists today are advancing their careers, managing their practices, and adapting to evolving trends in eyecare.

New Content
24-Month ELIOS Data: IOP, Medication, and Safety Outcomes
Clinical Studies & Trials
24-Month ELIOS Data: IOP, Medication, and Safety Outcomes
November 12, 2026
Systems That Keep Patients Buying Lenses In-House
Practice Metrics & Analytics
Systems That Keep Patients Buying Lenses In-House
November 12, 2026
Recently Published
A Concise Workflow for Identifying and Monitoring Glaucoma Suspects
CLINICAL GUIDES
A Concise Workflow for Identifying and Monitoring Glaucoma Suspects

Review step by step pearls for diagnosing and managing glaucoma suspects, and how a shift toward earlier procedural intervention is reducing drop burden.

Nick Bruns, OD, FAAONovember 11, 2026
Remigromig in DME: What BRUNELLO Shows and What BAROLO Must Answer
CLINICAL STUDIES & TRIALS
Remigromig in DME: What BRUNELLO Shows and What BAROLO Must Answer

Join Drs. Rishi Singh and Donald D'Amico to review the results of the phase 3 BRUNELLO trial of Remigromig for DME and implications for the BAROLO trial.

2026 Optometrist Report
OPTOMETRY INDUSTRY INFO
2026 Optometrist Report

Download the free report to understand how optometrists today are advancing their careers, managing their practices, and adapting to evolving trends in eyecare.

Natalie Osayande, OD, MSNovember 9, 2026
2026 Contact Lens Report

2026 Contact Lens Report

Download the free report to learn how optometrists are managing their contact lens practices in 2026!

Learn More
Latest Stories
The Empire Forum debuts in NYC with full day of retina pipeline, industry, and investor talks
November 13, 2026
The Empire Forum debuts in NYC with full day of retina pipeline, industry, and investor talks

Co-chairs Rishi Singh, MD, and David Eichenbaum, MD, led the inaugural meeting, which is set to return in 2027.

VeonGen on track for phase 3 Stargardt trial after FDA meeting
November 12, 2026
VeonGen on track for phase 3 Stargardt trial after FDA meeting

Phase 1/2 trial data demonstrate favorable safety profile and BCVA improvements; company has met with the FDA to plan the phase 3 program.

Scope launches OPTASE Heat Mask Pro for dry eye relief
November 12, 2026
Scope launches OPTASE Heat Mask Pro for dry eye relief

New addition to the OPTASE product line of dry eye management solutions delivers targeted and symptomatic relief via Hydrobead moist heat technology.

Clinical
Geographic Atrophy: Why Early Detection is the New Standard of Care
RETINAL DISEASE
Geographic Atrophy: Why Early Detection is the New Standard of Care

How clinical data from the past three years have shifted the treatment landscape and reformed the clinical calculus when it comes to managing geographic atrophy patients.

Saagar Pandit, MD, MPHNovember 13, 2026
24-Month ELIOS Data: IOP, Medication, and Safety Outcomes
CLINICAL STUDIES & TRIALS
24-Month ELIOS Data: IOP, Medication, and Safety Outcomes

Sit down with Drs. Mark Gallardo and Steven Sarkisian to review 24-month findings from the pivotal trial for ELIOS combined with cataract surgery.

A Concise Workflow for Identifying and Monitoring Glaucoma Suspects
CLINICAL GUIDES
A Concise Workflow for Identifying and Monitoring Glaucoma Suspects

Review step by step pearls for diagnosing and managing glaucoma suspects, and how a shift toward earlier procedural intervention is reducing drop burden.

Nick Bruns, OD, FAAONovember 11, 2026
Careers
Systems That Keep Patients Buying Lenses In-House
PRACTICE METRICS & ANALYTICS
Systems That Keep Patients Buying Lenses In-House

Consider approaches optometrists can take to increase the number of patients who purchase contact lenses at the office instead of online retailers.

2026 Optometrist Report
OPTOMETRY INDUSTRY INFO
2026 Optometrist Report

Download the free report to understand how optometrists today are advancing their careers, managing their practices, and adapting to evolving trends in eyecare.

Natalie Osayande, OD, MSNovember 9, 2026
How DTC Advertising is Driving Presbyopia Drop Conversations in Practice
PRESBYOPIA
How DTC Advertising is Driving Presbyopia Drop Conversations in Practice

Joins Drs. Coats, Davison, Ramsey and Schaeffer to review how direct-to-consumer (DTC) advertising impacts patient conversations about presbyopia drops.

Sponsored Content
The Ultimate Guide to TOTAL30® Multifocal for Astigmatism
PRIMARY CARE

The Ultimate Guide to TOTAL30® Multifocal for Astigmatism

Drs. Cifuentes and Lagunas offer insight into TOTAL30® Multifocal for Astigmatism, a modern solution designed for presbyopic patients with astigmatism, providing comfort and clear vision for both distance and near tasks.1

Our industry partners

ZEISS
National Vision
EssilorLuxottica
Essilor
Johnson & Johnson Vision
ZEISS Professional Education

Find your next eyecare job

Browse Eyecare Jobs (1,000+)Post a Job

Find your next eyecare job